Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04409860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Study acronym: CQGOG0102
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 11, 2023 (before its estimated April 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 2023 to Apr 2024
    • Study completion date: Apr 2028 to Apr 2029
    v4
  2. Study description revisedv3
  3. Eligibility criteria shortened, about 4 words
    • Study description shortened, about 3 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this trial was to evaluate the efficacy of adjuvant chemotherapy in the locally advanced cervical cancer with residual lesions after concurrent chemoradiation therapy.
Trial Details
NCT Number NCT04409860
Lead Sponsor Chongqing University Cancer Hospital
Conditions
(from sponsor)		 Cervical Cancer
Related terms Uterine Cervical Neoplasms
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov